Total Marrow And Lymphoid Irradiation (Tmli) At A Dose Of 2000cgy In Combination With Post-Transplant Cyclophosphamide (Ptcy)-Based Graft Versus Host Disease (Gvhd) Prophylaxis Is Safe And Associated With Favorable Gvhd-Free/Relapse-Free Survival At 1 Year In Patients With Acute Myeloid Leukemia (Aml)